Erasca (ERAS) shares were down roughly 15% in recent Wednesday trading after BofA Securities downgraded the precision oncology company's stock to underperform.
Trading volume stood at over 2.5 million shares, compared with a daily average of about 970,000 shares.
Price: 1.37, Change: -0.24, Percent Change: -14.69